Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes!

AFP AFP, Alpha Fetoprotein HCC, Hepatocellular Carcinoma HNF-1, Hepatocyte nuclear factor HPAFP, Hereditary Persistence of Alpha Fetoprotein chronic liver disease hereditary persistence AFP (HPAFP) non-alcoholic fatty liver disease

Journal

Journal of clinical and experimental hepatology
ISSN: 0973-6883
Titre abrégé: J Clin Exp Hepatol
Pays: India
ID NLM: 101574137

Informations de publication

Date de publication:
Historique:
received: 12 11 2020
accepted: 24 12 2020
entrez: 13 9 2021
pubmed: 14 9 2021
medline: 14 9 2021
Statut: ppublish

Résumé

Alpha-fetoprotein (AFP) is a glycoprotein secreted by the embryonic liver and is expressed in tumours with high mitotic index such as hepatocellular carcinoma (HCC) and germ cell tumours. Detection of elevated AFP is strongly associated with underlying HCC or occasionally germ cell tumour. Modest elevation of AFP can be observed in patients with chronic viral hepatitis particularly with active replication. Very rarely, incidental detection of raised AFP in a genetically susceptible individuals has been reported in the absence of the underlying malignant process. This condition is termed as hereditary persistence of AFP (HPAFP), a rare disorder with an autosomal dominant pattern of inheritance. HPAFP should be suspected in patients with high AFP in the absence of radiological evidence of HCC or germ cell tumour. The diagnosis is confirmed by the identification of AFP gene mutation. AFP gene is located in the long arm of chromosome 4. The most common single-nucleotide polymorphism in HPAFP is 119 G > A, rs587776861, interestingly reported only in six family clusters worldwide. Despite being described as a benign disorder, its implication in patients with underlying chronic liver disease needs further clarification. Here, we describe 3 patients in their forties with chronic liver disease and persistently elevated levels of AFP, where genetic studies confirmed HPAFP. None of our patients had HCC despite extensive investigations.

Identifiants

pubmed: 34511823
doi: 10.1016/j.jceh.2020.12.008
pii: S0973-6883(20)30188-2
pmc: PMC8414326
doi:

Types de publication

Case Reports

Langues

eng

Pagination

616-618

Informations de copyright

© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Références

Hum Mol Genet. 1993 Apr;2(4):379-84
pubmed: 7684942
Am J Med Sci. 1992 Mar;303(3):157-9
pubmed: 1375809
Pediatr Blood Cancer. 2009 Mar;52(3):403-5
pubmed: 18985745
Cancer Res. 1972 May;32(5):979-82
pubmed: 4111729
Neth J Med. 2010 Nov;68(11):354-8
pubmed: 21116028
Exp Biol Med (Maywood). 2001 May;226(5):377-408
pubmed: 11393167
Biochemistry (Mosc). 2000 Jan;65(1):117-33
pubmed: 10702646
Gastroenterology. 2004 Jan;126(1):308-17
pubmed: 14699509
ACG Case Rep J. 2017 Mar 1;4:e33
pubmed: 28286798
Scand J Clin Lab Invest. 1956;8(2):174
pubmed: 13351554

Auteurs

Vaibhav Patil (V)

Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India.

Dinesh Jothimani (D)

Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India.

Gomathy Narasimhan (G)

Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India.

Silas Danielraj (S)

Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India.

Mohamed Rela (M)

Institute of Liver Disease and Transplantation, Dr. Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, Tamilnadu, India.

Classifications MeSH